search
Back to results

A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.Connect

Primary Purpose

Diabetes Mellitus, Type 1

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Teens.Connect
Sponsored by
Yale University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetes Mellitus, Type 1

Eligibility Criteria

11 Years - 14 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • diagnosed with T1D for at least 6 months;
  • age 11 to 14 years
  • naïve to TEENCOPE and/or Managing Diabetes
  • assent and parent/guardian consent to participate in the study

Exclusion Criteria:

  • medical condition that impacts cortisol functioning
  • takes medications that impact cortisol, except diabetes medications
  • sleeps less than 6 hours per night
  • smokes
  • takes oral contraceptives

Sites / Locations

  • Yale School of Nursing

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

No Intervention

Arm Label

Teens.Connect

Control

Arm Description

The Teens-Connect internet-based program has two complementary components - TEENCOPE and Managing Diabetes. Managing Diabetes consists of 5 sessions on educational content related to diabetes self management targeted to adolescents. TEENCOPE consists of a series of 5 sessions designed to increase children's sense of competence and mastery by retraining inappropriate or non-constructive coping styles and forming more positive styles and patterns of behavior. Each week a new 30-45 minute session is uploaded to a password-protected website on the Yale server for youth to complete. Youth are grouped with 8-12 peers who complete the same weekly sessions in an asynchronous manner. Youth interact with each other on an online discussion board moderated by a clinical psychologist.

Wait listing will serve as the control condition. Usual care at the Yale Pediatric Diabetes Center consists of quarterly visits with physicians and nurse practitioners, accessibility to nutritional and psychological consultation, and 24/7 on call service. Following completion of the 6 month data point, youth will be offered the opportunity to participate in the internet program.

Outcomes

Primary Outcome Measures

Glycosylated Hemoglobin (HbA1c)
Bayer Diagnostics DCA2000® (normal range = 4.2-6.3%)
Glycosylated Hemoglobin (HbA1c)
Bayer Diagnostics DCA2000® (normal range = 4.2-6.3%)

Secondary Outcome Measures

Perceived Stress Scale
A 14-item scale that measures the degree to which situations in one's life are appraised as stressful. Items assess feelings of stress, hassles, and coping during the past month. Respondents rate items on a 5-point Likert scale ranging from 0 (never) to 4 (very often), with higher scores indicative of greater perceived stress and less effective coping.
Perceived Stress Scale
A 14-item scale that measures the degree to which situations in one's life are appraised as stressful. Items assess feelings of stress, hassles, and coping during the past month. Respondents rate items on a 5-point Likert scale ranging from 0 (never) to 4 (very often), with higher scores indicative of greater perceived stress and less effective coping.
Adolescent Stress Questionnaire (ASQ)
A 94-item inventory of common adolescent stressors. Each item (stressor) is rated on a 5-point Likert scale where 1=Not at all stressful (or is irrelevant to me); 2=A little stressful; 3=Moderately stressful; 4=Quite stressful; and 5=Very stressful.
Adolescent Stress Questionnaire (ASQ)
A 94-item inventory of common adolescent stressors. Each item (stressor) is rated on a 5-point Likert scale where 1=Not at all stressful (or is irrelevant to me); 2=A little stressful; 3=Moderately stressful; 4=Quite stressful; and 5=Very stressful.
Responses to Stress Questionnaire for Diabetes (RSQ)
A 69-item scale asking the participant to report frequency of diabetes related stressors (12 items) and their responses to those stressors (57 items). Frequencies are reported on a 4-point scale ranging from 0 (never) to 3 (almost every day) for stressors, and 1 (not at all) to 4 (a lot) for stress responses.
Responses to Stress Questionnaire for Diabetes (RSQ)
A 69-item scale asking the participant to report frequency of diabetes related stressors (12 items) and their responses to those stressors (57 items). Frequencies are reported on a 4-point scale ranging from 0 (never) to 3 (almost every day) for stressors, and 1 (not at all) to 4 (a lot) for stress responses.
Stress Biomarkers
cortisol, alpha-amylase (s-AA), and salivary immunoglobulin A (s-IgA) determined by salivary collection at awakening and 30-45 minutes later over 3 days
Stress Biomarkers
cortisol, alpha-amylase (s-AA), and salivary immunoglobulin A (s-IgA) determined by salivary collection at awakening and 30-45 minutes later over 2 days
Awakening and sleep time
wrist-worn accelerometer
Awakening and sleep time
wrist-worn accelerometer
Genotype & DNA Methylation
Saliva collection
DNA Methylation
Saliva collection

Full Information

First Posted
November 18, 2016
Last Updated
April 1, 2019
Sponsor
Yale University
Collaborators
Miller Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT02970656
Brief Title
A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.Connect
Official Title
A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.Connect
Study Type
Interventional

2. Study Status

Record Verification Date
April 2019
Overall Recruitment Status
Completed
Study Start Date
February 8, 2017 (Actual)
Primary Completion Date
February 28, 2019 (Actual)
Study Completion Date
February 28, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yale University
Collaborators
Miller Foundation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This feasibility/pilot study has three purposes. First, the investigators will determine the feasibility of collecting saliva to measure stress biomarkers over three days at home in youth. Second, the investigators will conduct a pilot study of the Teens.Connect Internet program for youth with type 1 diabetes to determine whether changes in stress biomarkers associate with self-reported perceived stress and HbA1c. Third, the investigators will examine the gene-environment interaction of the top 14 targeted candidate genes and epi-genome wide effects of teens' stress biomarkers and its influence on blood glucose levels over time.
Detailed Description
Intensive management of type 1 diabetes (T1D) among youth as recommended by the American Diabetes Association requires a complex set of self-management activities that create high levels of perceived stress in youth and families. In individuals exposed to chronic stress, such as that of a chronic condition, the body responds with physiological and hormonal responses to adapt. These responses can be harmful (e.g., higher glucose levels, higher HbA1c). Such harmful effects may be ameliorated by programs that reduce psychosocial stress. The investigators have found an Internet-delivered coping skills training program combined with a diabetes education program significantly improved HbA1c and QOL for youth with T1D. Self-reported perceived stress mediated these outcomes. There has been little to no examination, however, of whether a reduction in self-reported perceived stress is associated with a reduction in biochemical markers of stress which could explain the positive impact on HbA1c. It is critically important to understand the physiologic as well as the psychosocial mechanisms associated with such interventions in order to improve glycemic control in youth with this chronic autoimmune condition. If such interventions affect biomarkers of stress, it would be important to strengthen the stress reduction activities embedded in such interventions, such as meditation, to further improve metabolic control. Thus, aims of this pilot/feasibility study are to: Determine the feasibility and reliability of collection of saliva for the measurement of three stress biomarkers at awakening and 30-45 minutes later over 3 days at home in 20 youth (age 11-14 years). These biomarkers include cortisol to assess hypothalamic-pituitary-adrenal axis functioning; alpha-amylase (s-AA) to assess the sympathetic-adrenal-medullary system, and salivary immunoglobulin A (s-IgA) to assess stress-related immune changes. This aim will allow the investigators to determine the feasibility of recruiting youth to provide such data in a larger trial by assessing the percent of youth who agree to participate and adhere to the salivary collection protocol, using actigraphy to document awakening time and Medication Event Monitoring System (MEMS) caps monitoring to determine time of salivary collection. Patterns and variability of stress biomarker levels over 3 days will be used to assess intra-individual variability and relationships with self-reported daily stressors and self-reported perceived stress. Conduct a pilot study of Teens.Connect, a combination of the investigators' previous TEENCOPE™ and Managing Diabetes programs with 40 youth to determine whether alterations in stress biomarkers are associated with self-reported perceived stress and HbA1c. Assess epigenetic components of these responses by examining the gene-environment interaction of the top 14 targeted candidate genes and epigenome wide effects of teens' stress biomarkers and their influence on HbA1c levels over time. Candidate genes will be measured at baseline and DNA methylation patterns will be measured at baseline and then again at 6 months follow-up using the Oragene saliva collection kits.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus, Type 1

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
29 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Teens.Connect
Arm Type
Experimental
Arm Description
The Teens-Connect internet-based program has two complementary components - TEENCOPE and Managing Diabetes. Managing Diabetes consists of 5 sessions on educational content related to diabetes self management targeted to adolescents. TEENCOPE consists of a series of 5 sessions designed to increase children's sense of competence and mastery by retraining inappropriate or non-constructive coping styles and forming more positive styles and patterns of behavior. Each week a new 30-45 minute session is uploaded to a password-protected website on the Yale server for youth to complete. Youth are grouped with 8-12 peers who complete the same weekly sessions in an asynchronous manner. Youth interact with each other on an online discussion board moderated by a clinical psychologist.
Arm Title
Control
Arm Type
No Intervention
Arm Description
Wait listing will serve as the control condition. Usual care at the Yale Pediatric Diabetes Center consists of quarterly visits with physicians and nurse practitioners, accessibility to nutritional and psychological consultation, and 24/7 on call service. Following completion of the 6 month data point, youth will be offered the opportunity to participate in the internet program.
Intervention Type
Behavioral
Intervention Name(s)
Teens.Connect
Intervention Description
Teens.Connect combines two internet psycho-educational programs, TEENCOPE™, an internet version of coping skills training using a graphic novel format combined with social media, and an internet diabetes problem-solving educational program (Managing Diabetes)
Primary Outcome Measure Information:
Title
Glycosylated Hemoglobin (HbA1c)
Description
Bayer Diagnostics DCA2000® (normal range = 4.2-6.3%)
Time Frame
baseline
Title
Glycosylated Hemoglobin (HbA1c)
Description
Bayer Diagnostics DCA2000® (normal range = 4.2-6.3%)
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Perceived Stress Scale
Description
A 14-item scale that measures the degree to which situations in one's life are appraised as stressful. Items assess feelings of stress, hassles, and coping during the past month. Respondents rate items on a 5-point Likert scale ranging from 0 (never) to 4 (very often), with higher scores indicative of greater perceived stress and less effective coping.
Time Frame
baseline
Title
Perceived Stress Scale
Description
A 14-item scale that measures the degree to which situations in one's life are appraised as stressful. Items assess feelings of stress, hassles, and coping during the past month. Respondents rate items on a 5-point Likert scale ranging from 0 (never) to 4 (very often), with higher scores indicative of greater perceived stress and less effective coping.
Time Frame
6 months
Title
Adolescent Stress Questionnaire (ASQ)
Description
A 94-item inventory of common adolescent stressors. Each item (stressor) is rated on a 5-point Likert scale where 1=Not at all stressful (or is irrelevant to me); 2=A little stressful; 3=Moderately stressful; 4=Quite stressful; and 5=Very stressful.
Time Frame
baseline
Title
Adolescent Stress Questionnaire (ASQ)
Description
A 94-item inventory of common adolescent stressors. Each item (stressor) is rated on a 5-point Likert scale where 1=Not at all stressful (or is irrelevant to me); 2=A little stressful; 3=Moderately stressful; 4=Quite stressful; and 5=Very stressful.
Time Frame
6 months
Title
Responses to Stress Questionnaire for Diabetes (RSQ)
Description
A 69-item scale asking the participant to report frequency of diabetes related stressors (12 items) and their responses to those stressors (57 items). Frequencies are reported on a 4-point scale ranging from 0 (never) to 3 (almost every day) for stressors, and 1 (not at all) to 4 (a lot) for stress responses.
Time Frame
baseline
Title
Responses to Stress Questionnaire for Diabetes (RSQ)
Description
A 69-item scale asking the participant to report frequency of diabetes related stressors (12 items) and their responses to those stressors (57 items). Frequencies are reported on a 4-point scale ranging from 0 (never) to 3 (almost every day) for stressors, and 1 (not at all) to 4 (a lot) for stress responses.
Time Frame
6 months
Title
Stress Biomarkers
Description
cortisol, alpha-amylase (s-AA), and salivary immunoglobulin A (s-IgA) determined by salivary collection at awakening and 30-45 minutes later over 3 days
Time Frame
over 3 days at baseline
Title
Stress Biomarkers
Description
cortisol, alpha-amylase (s-AA), and salivary immunoglobulin A (s-IgA) determined by salivary collection at awakening and 30-45 minutes later over 2 days
Time Frame
over 2 days at 6 months
Title
Awakening and sleep time
Description
wrist-worn accelerometer
Time Frame
over 3 days at baseline
Title
Awakening and sleep time
Description
wrist-worn accelerometer
Time Frame
over 2 days at 6 months
Title
Genotype & DNA Methylation
Description
Saliva collection
Time Frame
baseline
Title
DNA Methylation
Description
Saliva collection
Time Frame
6 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
11 Years
Maximum Age & Unit of Time
14 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: diagnosed with T1D for at least 6 months; age 11 to 14 years naïve to TEENCOPE and/or Managing Diabetes assent and parent/guardian consent to participate in the study Exclusion Criteria: medical condition that impacts cortisol functioning takes medications that impact cortisol, except diabetes medications sleeps less than 6 hours per night smokes takes oral contraceptives
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Margaret Grey, DrPH, RN
Organizational Affiliation
Yale School of Nursing
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Jacquelyn Taylor, PhD, PNP-BC
Organizational Affiliation
Yale School of Nursing
Official's Role
Principal Investigator
Facility Information:
Facility Name
Yale School of Nursing
City
West Haven
State/Province
Connecticut
ZIP/Postal Code
06516-7399
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.Connect

We'll reach out to this number within 24 hrs